Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...
Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds-those with high potency, selectivity, and favorable metabolic properties-at the earliest stages ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...
Even though AI-designed drugs aren’t yet a household term for FDA-approved, commercially available therapies, they are a reality in clinical development pipelines. In spring 2024, CBER reported more ...
This article is based on a poster originally authored by Barbie Wang, Maria Giebler, Adrian Freeman, Karen Hogg, Adam Corrigan and Hitesh Sanganee. This poster is being hosted on this website in its ...
The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...
Cancer is the second leading cause of death worldwide. Since age is one of the risk factors for the development of cancer, ...
Molecular crystal polymorphism does not sound like something you want in your kitchen, but you've probably had experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback